Income statement - the Novozymes Group

Audited by PwC

	Note				2010	2009
					DKK million	DKK million

		1,	2	Revenue	9,724	8,448
		3,	6	Cost of goods sold	4,312	3,748
				Gross profit	5,412	4,700

		3,	6	Sales and distribution costs	1,242	1,118
		3,	6	Research and development costs	1,360	1,207
3,	4,	5,	6	Administrative costs	762	751
			7	Other operating income, net	69	64
				Operating profit / EBIT	2,117	1,688

			8	Financial income	113	153
			9	Financial costs	107	220
				Profit before tax	2,123	1,621

			10	Corporation tax	509	427
				Net profit	1,614	1,194

				Attributable to:
				Shareholders in the parent company	1,613	1,194
				Minority interests	1	-
					1,614	1,194

				Proposed dividend per share	DKK 8.00	DKK 5.75

			20	Earnings per share	DKK 25.75	DKK 19.24
			20	Earnings per share, diluted	DKK 25.25	DKK 18.93